Literature DB >> 24271830

lontophoretic Devices for Drug Delivery.

P Tyle1.   

Abstract

Transdermal drug delivery of ionized drugs can be enhanced by iontophoresis. Drug in the ionic form, contained in some reservoir, can be "phoresed" through the skin with a small current across two electrodes, one above the reservoir and one at a distal skin location. Positive ions can be introduced from the positive pole, or negative ions from the negative pole. The design and development of iontophoretic devices are rather simple. Some of the principles of operation and the advantages/disadvantages and clinical implications associated with these devices are outlined in this review.

Entities:  

Year:  1986        PMID: 24271830     DOI: 10.1023/A:1016327822325

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  42 in total

1.  The use of magnesium sulphate iontophoresis in the treatment of subdeltoid bursitis.

Authors:  M V WEINSTEIN; A GORDON
Journal:  Phys Ther Rev       Date:  1958-02

2.  [Study of the electrolytic introduction of ions by means of radioactive isotopes].

Authors:  A STROHL; J VERNE; J C ROUCAYROL; P F CECCALDI
Journal:  C R Seances Soc Biol Fil       Date:  1950-06

3.  Effectiveness of antihistaminic compounds introduced into normal human skin by iontophoresis.

Authors:  W B SHELLEY; J C McCONAHY; E N HESBACHER
Journal:  J Invest Dermatol       Date:  1950-11       Impact factor: 8.551

4.  Conductivity of drugs used for iontophoresis.

Authors:  L P Gangarosa; N H Park; B C Fong; D F Scott; J M Hill
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

5.  Effect of iontophoresis of vasopressin on lateral septal neurons.

Authors:  J E Marchand; N Hagino
Journal:  Exp Neurol       Date:  1982-12       Impact factor: 5.330

6.  Copper iontophoresis in male contraception.

Authors:  S S Riar; R C Sawhney; J Bardhan; P Thomas; R K Jain; A K Kain
Journal:  Andrologia       Date:  1982 Nov-Dec       Impact factor: 2.775

7.  The treatment of Peyronie's disease by iontophoresis of C21 esterified glucocortocoids.

Authors:  S H Rothfeld; W Murray
Journal:  J Urol       Date:  1967-05       Impact factor: 7.450

8.  [Treatment of patients with neurologic syndromes of cervical osteochondrosis by electrophoresis of papaverine and nicotinic acid using sinusoidally-modulated and diadynamic currents].

Authors:  A N Ostrakhovich; N I Strelkova
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1982

9.  Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin.

Authors:  B Kari
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

10.  Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis).

Authors:  L P Gangarosa; N H Park; C A Wiggins; J M Hill
Journal:  J Pharmacol Exp Ther       Date:  1980-03       Impact factor: 4.030

View more
  13 in total

1.  Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery.

Authors:  D Bommannan; H Okuyama; P Stauffer; R H Guy
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

2.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

3.  Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis.

Authors:  M J Pikal
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

4.  Iontophoretic transport of a homologous series of ionized and nonionized model compounds: influence of hydrophobicity and mechanistic interpretation.

Authors:  S Del Terzo; C R Behl; R A Nash
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

5.  Electrode material in iontophoresis.

Authors:  L E Linblad; L Ekenvall
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

6.  A new system for in vitro studies of iontophoresis.

Authors:  P Glikfeld; C Cullander; R S Hinz; R H Guy
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

7.  Electrode material in iontophoresis.

Authors:  P Tyle
Journal:  Pharm Res       Date:  1988-04       Impact factor: 4.200

Review 8.  Pharmacokinetic considerations in the use of newer transdermal formulations.

Authors:  G Ridout; G C Santus; R H Guy
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

9.  Reverse iontophoresis: development of a noninvasive approach for glucose monitoring.

Authors:  G Rao; P Glikfeld; R H Guy
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

10.  Iontophoretic delivery of a series of tripeptides across the skin in vitro.

Authors:  P G Green; R S Hinz; A Kim; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.